December 6, 2022
NFL Stars Don Customized Cleats to Raise Awareness for Type 1 Diabetes
November 17, 2022
Breakthrough T1D Celebrates Tzield™ (teplizumab-mzwv) Approval
November 17, 2022
FDA Approves Tzield™ (teplizumab-mzwv)—a Drug that Can Delay the Onset of Type 1 Diabetes for Approximately 2 Years
November 7, 2022
Breakthrough T1D Moves the Type 1 Diabetes Community #ForwardAs1 in Recognition of National Diabetes Awareness Month
November 3, 2022
Breakthrough T1D Presents South Florida Resident John Cammett with the 2022 John Brady Award for Innovation
November 3, 2022
Breakthrough T1D Honors Dallas Resident Kim Roosevelt with the 2022 Jim Tyree Chairman’s Award
November 3, 2022
Breakthrough T1D Honors Game2Give Creators Dan Connors and Hans ten Cate with the 2022 Huntsman Family Community Engagement Award
November 3, 2022
Breakthrough T1D Honors Salem, Virginia Resident Sally Southard with the 2022 Erwin Lurie Award at the Annual One Conference
November 3, 2022
Breakthrough T1D Encouraged by Provention Bio Update on Teplizumab
October 24, 2022
Breakthrough T1D mourns Jean Kuczka, T1D Parent and Long Time Breakthrough T1D Volunteer
